NCT00567060View on ClinicalTrials.gov

Efficacy and Safety of Piracetam Taken for 12 Months in Subjects Suffering From Mild Cognitive Impairment (MCI)

NACompletedINTERVENTIONAL
Enrollment

676

Participants

Timeline

Start Date

May 31, 2000

Primary Completion Date

January 31, 2004

Study Completion Date

January 31, 2004

Conditions
Memory Disorders
Interventions
DRUG

Piracetam

Sponsors

Lead Sponsor

UCB Pharma
All Listed Sponsors
lead

UCB Pharma

INDUSTRY

NCT00567060 - Efficacy and Safety of Piracetam Taken for 12 Months in Subjects Suffering From Mild Cognitive Impairment (MCI) | Biotech Hunter | Biotech Hunter